Bluejay Capital Partners recapitalizes quality life science logistics & transportation

Bluejay Capital Partners, LLC (Bluejay Capital), a specialist in partnering and investing in transportation and logistics businesses, has recapitalized Quality Life Science Logistics & Transportation (QLS), a premier provider of specialized cold chain transportation and logistics solutions for the pharmaceutical and life sciences industries. Terms of the transaction were not disclosed.

QLS specializes in providing state-of-the-art dual temperature trailers designed to handle refrigerated, frozen and ambient high-value, life-saving cargo.

“QLS has an exceptional history of delivering high-value cold chain transportation services using advanced technology and a resolute team of experts who provide white glove service to customers. The QLS team understands the critical importance of maintaining the integrity and security of pharmaceutical products throughout the supply chain,” said Billy Hart, founding Managing Partner of Bluejay Capital. “The formidable team at QLS, coupled with the Bluejay Capital team’s growth and industry experience, creates a powerful alliance. We are thrilled to partner with QLS.”

“Our partnership with Bluejay Capital marks the beginning of the next chapter of growth for QLS and our dedicated employees. Our core values, mission, and culture will not change. We are proud of what we have created and are excited to advance our industry-leading position and expand our market reach,” said Terry Fewless, founder of QLS, who will retain a significant ownership stake in the business. “The Bluejay team is definitely the right partner for QLS.”

Bluejay Capital financed the transaction with Revelation Partners, the largest secondaries investment manager providing flexible capital solutions exclusively to the private healthcare ecosystem, and Oxford Finance LLC, a specialty finance firm with significant experience in healthcare and business services. McGuireWoods LLP served as legal counsel to Bluejay Capital.